Compare SPCB & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPCB | COCH |
|---|---|---|
| Founded | 1988 | 1995 |
| Country | Israel | United States |
| Employees | N/A | 47 |
| Industry | Semiconductors | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8M | 47.1M |
| IPO Year | 2004 | N/A |
| Metric | SPCB | COCH |
|---|---|---|
| Price | $8.62 | $0.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 47.7K | ★ 152.8K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.58 |
| Revenue Next Year | $27.13 | N/A |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.51 | $0.36 |
| 52 Week High | $13.57 | $1.91 |
| Indicator | SPCB | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 42.79 |
| Support Level | $8.51 | $0.64 |
| Resistance Level | $8.69 | $0.73 |
| Average True Range (ATR) | 0.45 | 0.04 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 25.70 | 29.65 |
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.